Patients on iOAT may also receive a co-prescription for OAT such as slow-release oral morphine or methadone to prevent withdrawal and cravings between iOAT doses. iOAT is considered an …

iOAT is an advanced and evidence-informed treatment approach for individuals with opioid use disorder. iOAT is prescribed by medical doctors. Clients administer the prescribed injectable …

Injectable opioid agonist treatment should be considered for people with severe opioid addiction who do not respond to oral treatments, as well as people who actively use illicit injectable opioids.

“Several randomized trials and cohort studies have shown that iOAT provided in dedicated clinics is feasible, safe, and effective when treating long-term, chronic injecting opioid users for whom …

Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT.

Background: Addressing inadequacies in the implementation of existing evidence-based approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative for …

National Injectable Opioid Agonist Treatment for Opioid Use Disorder Operational Guidance (iOAT Operational Guidance), a partner guideline to this clinically-focused document, provides …

Injectable opioid agonist treatment (iOAT) is an emerging evidence-based option in the continuum of care for opioid use disorder in parts of Canada. Our study objective was to identify and …

Injectable OAT (iOAT) take-home doses were previously not an eligible option, and were made available for the first time in several sites to align with public health measures.

The iOAT is based on an ICAO flight plan format for military use and contains specific additional information. The iOAT FPL has been deployed in line with the EUROCONTROL Guidelines for …